Literature DB >> 28029762

Prevascularization of Decellularized Porcine Myocardial Slice for Cardiac Tissue Engineering.

Pawan Kc1, Mickey Shah1,2, Jun Liao3, Ge Zhang1.   

Abstract

Prevacularization strategies have been implemented in tissue engineering to generate microvasculature networks within a scaffold prior to implantation. Prevascularizing scaffolds will shorten the time of functional vascular perfusion with host upon implantation. In this study, we explored key variables affecting the interaction between decellularized porcine myocardium slices (dPMSs) and reseeded stem cells toward the fabrication of prevascularized cardiac tissue. Our results demonstrated that dPMS supports attachment of human mesenchymal stem cells (hMSCs) and rat adipose derived stem cells (rASCs) with high viability. We found that cell seeding efficiency and proliferation are dPMS thickness dependent. Compared to lateral cell seeding, bilateral cell seeding strategy significantly enhanced seeding efficiency, infiltration, and growth in 600 μm dPMS. dPMS induced endothelial differentiation and maturation of hMSCs and rASCs after 1 and 5 days culture, respectively. These results indicate the potential of dPMS as a powerful platform to develop prevascularized scaffolds and fabricate functional cardiac patches.

Entities:  

Keywords:  cardiac tissue engineering; decellularized extracellular matrix; human mesenchymal stem cells; prevascularization; rat adipose derived stem cells; stem cell differentiation

Mesh:

Year:  2017        PMID: 28029762      PMCID: PMC6445257          DOI: 10.1021/acsami.6b15291

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  11 in total

1.  A microfluidic competitive immuno-aggregation assay for high sensitivity cell secretome detection.

Authors:  Fan Liu; Pawan Kc; Liwei Ni; Ge Zhang; Jiang Zhe
Journal:  Organogenesis       Date:  2018-06-08       Impact factor: 2.500

Review 2.  Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs.

Authors:  Yu-Chun Chang; Gabriel Mirhaidari; John Kelly; Christopher Breuer
Journal:  Curr Cardiol Rep       Date:  2021-03-17       Impact factor: 2.931

3.  In Vivo Assessment of Decellularized Porcine Myocardial Slice as an Acellular Cardiac Patch.

Authors:  Mickey Shah; Pawan Kc; Ge Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2019-06-28       Impact factor: 9.229

4.  Acellular Myocardial Scaffolds and Slices Fabrication, and Method for Applying Mechanical and Electrical Simulation to Tissue Construct.

Authors:  Bo Wang; Mickey Shah; Lakiesha N Williams; Amy L de Jongh Curry; Yi Hong; Ge Zhang; Jun Liao
Journal:  Methods Mol Biol       Date:  2022

5.  Cardiac Progenitor Cells: The Matrix Has You.

Authors:  Clotilde Castaldo; Isotta Chimenti
Journal:  Stem Cells Transl Med       Date:  2018-04-24       Impact factor: 6.940

6.  3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts.

Authors:  Nadav Noor; Assaf Shapira; Reuven Edri; Idan Gal; Lior Wertheim; Tal Dvir
Journal:  Adv Sci (Weinh)       Date:  2019-04-15       Impact factor: 16.806

Review 7.  Cardiac tissue-derived extracellular matrix scaffolds for myocardial repair: advantages and challenges.

Authors:  Pawan Kc; Yi Hong; Ge Zhang
Journal:  Regen Biomater       Date:  2019-04-22

Review 8.  Decellularized extracellular matrix scaffolds: Recent trends and emerging strategies in tissue engineering.

Authors:  Xuewei Zhang; Xi Chen; Hua Hong; Rubei Hu; Jiashang Liu; Changsheng Liu
Journal:  Bioact Mater       Date:  2021-09-23

9.  Vasculogenic and angiogenic potential of adipose stromal vascular fraction cell populations in vitro.

Authors:  Joseph S Zakhari; Jacob Zabonick; Brian Gettler; Stuart K Williams
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

10.  A Thin Layer of Decellularized Porcine Myocardium for Cell Delivery.

Authors:  Mickey Shah; Pawan Kc; Katherine M Copeland; Jun Liao; Ge Zhang
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.